// App-Quantinova.ai

: CAPTAIN: Effects of Body Mass Index (BMI) on Response to Triple Therapy in Patients With Inadequately Controlled Asthma on Inhaled Corticosteroids/Long-acting β2-agonists (ICS/LABA)

Researchers

Presenter

  • Diego Maselli

Principal Investigators

  • Sarah Chang

  • Andrew Fowler

  • Mark Liu

  • Michael Manning

  • David Mannino

  • Joseph Spahn

  • Agne Zarankaite

  • Edward Kerwin

Medical Centers

  • University of Texas at San Antonio, San Antonio, TX

  • GSK, Research Triangle Park, NC, USA

  • GSK, Stockley Park West, Uxbridge, Middlesex, United Kingdom,

  • Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA

  • Allergy, Asthma and Immunology Associates, Scottsdale, AZ, USA

  • Crisor LLC Research, Clinical Research Institute of Southern Oregon, Medford, OR, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Body mass index

Drug/Treatment

  • Umeclidinium

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

  • Parallel Group

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved